At Medigrowth, we’re on a journey to provide legal access to medicinal cannabis and medical marijuana to Australian patients & doctors with permission from the TGA and ODC. With each and every milestone achieved we consolidate a resolute commitment to ourselves, our industry partners and Australian patients.
Medigrowth Australia was founded in 2017 by its Directors Adam Guskich & Todd McClellan.
“We share a resolute belief in Medicinal Cannabis, along with our combined vision for creating a company with the ability to effect substantial positive change in patient wellbeing” This is the motivational driver for success.
Our genuine ‘seed to solution’ commitment.
Fully Licensed with the Office of Drug Control for Cultivation, Research & Manufacture, Medigrowth offers a genuine ‘seed to solution’ commitment to Australian patients and industry partners.
World class cGMP design for purpose built facility to be located in regional Victoria.
The Medigrowth Australia Centre for Excellence – Offering state of the art technology in extraction and manufacturing, cultivation, analytical and laboratory services, genetics supply and University led research. At Medigrowth, we understand every critical element in the supply chain, allowing for the seamless integration between meeting individual patient needs and serving our industry partners.
Medigrowth Australia is committed to ongoing contribution to Medicinal Cannabis Research. In partnership with Deakin University, our collaborative Research & Development initiatives, Joint PHD programs & Postgraduate training research programs will be implemented to further develop and explore the therapeutic benefits of cannabinoids & full spectrum cannabis extracts.
Our ability to utilise existing expertise and consolidate University led research, plant genetics programs, cannabinoid research, selective breeding programs and proprietary cultivation techniques including Australia’s first commercial aquaponics grown cannabis program will offer long term industry engagement and academic contribution.
Enabling engaging, high value research opportunities for Medigrowth to Inspire. Innovate. Exceed.
The Internet of Cannabis
Working with researchers at Deakin University, the team at Medigrowth Australia are committed to innovate, create and develop. Subscribe to our newsletter for updates on current Research initiatives, including the 2021 Internet of Cannabis – a high tech thermal/HD plant monitoring platform integrating IOT & machine learning to implement novel Artificial Intelligence algorithms for tracking plant physiology and environmental parameters.
A stong focus in sustainability by Medigrowth and a vision for the future.
Targeting 100% renewable energy – harnessing the power of nature for a truly sustainable future. Medigrowth is currently utilising solar for >50% of its energy needs and is committed to carbon neutrality by 2025 and carbon negative operations by 2030. Sustainability by Medigrowth.
For more information regarding our business, our products and services or any general corporate enquiry, please get in touch.
© Copyright 2019 Medigrowth Australia Pty Ltd.